The global viscosupplementation market was valued at USD 2.75 billion in 2023 and is expected to grow from USD 2.90 billion in 2024 to USD 4.60 billion by 2032, reflecting a CAGR of 5.9% over the forecast period. In 2023, North America led the market, holding a dominant share of 45.45%.

Viscosupplementation is a medical procedure that involves injecting hyaluronic acid into diarthrodial joints, including the knee, hip, shoulder, and elbow. This treatment helps restore the rheological properties of synovial fluid, providing pain relief, reducing inflammation, and offering chondroprotective benefits.

Request a Free Sample PDF Brochure : https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/viscosupplementation-market-110550

The global viscosupplementation market is experiencing significant growth, driven by advancements in osteoarthritis treatment and an increasing demand for minimally invasive procedures. This article delves into the key industry developments, market drivers and restraints, competitive landscape, market segments, regional insights, and future market scope.

Key Industry Development

In November 2024, the 4th Annual Conference on Orthopedics, Rheumatology, and Musculoskeletal Disorders was held in Bangkok, Thailand. This conference provided a platform for healthcare professionals to gain knowledge in these fields. One of the key topics discussed was osteoarthritis treatment with hyaluronic acid-based injections, highlighting the growing interest and investment in viscosupplementation therapies.

Top Companies in the Market

• Zimmer Biomet (U.S.)

• Anika Therapeutics, Inc. (U.S.)

• Bioventus (U.S.)

• Biotech (Switzerland)

• SEIKAGAKU CORPORATION (Japan)

• Ferring (Switzerland)

• Sanofi (France)

• APTISSEN (Switzerland)

• Avanos Medical, Inc. (U.S.)

Market Drivers & Restraints

The primary driver of the viscosupplementation market is the rising prevalence of osteoarthritis (OA) worldwide. OA is a chronic degenerative joint disease and a leading cause of disability. The aging global population and increasing obesity rates contribute to the growing incidence of OA, thereby boosting the demand for viscosupplementation treatments. Additionally, patients' preference for minimally invasive procedures to manage joint pain and delay surgical interventions further propels market growth.

However, the market faces certain restraints. The high cost of viscosupplementation treatments can be a barrier for patients, especially in developing regions. Moreover, the need for multiple injections in some treatment regimens may deter patient compliance. There is also a lack of awareness about viscosupplementation in certain populations, which can limit market expansion.

Market Report Coverage

The viscosupplementation market report provides a comprehensive analysis of current trends, growth drivers, challenges, and opportunities. It includes detailed insights into market segmentation by type, source, application, and end-user. The report also offers an in-depth examination of the competitive landscape, profiling key players and their strategies. Regional analyses highlight market dynamics across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Market Competitive Landscape

The viscosupplementation market is characterized by the presence of several key players focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their market position. Companies like Zimmer Biomet, Anika Therapeutics, and Bioventus are investing in research and development to introduce advanced hyaluronic acid-based injections with improved efficacy and patient compliance. Collaborations with healthcare institutions and participation in global conferences further enhance their market presence.

Market Segments

By type, the viscosupplementation market is segmented into single-injection and multi-injection (three-injection) procedures. The single-injection segment is gaining popularity due to its convenience and reduced treatment time, leading to better patient adherence. However, the three-injection procedure segment continues to hold a significant market share, attributed to its established efficacy and widespread adoption in clinical practices.

Market Regional Insights

North America dominated the viscosupplementation market, holding a market share of 45.45% in 2023. This dominance is attributed to the high prevalence of osteoarthritis, advanced healthcare infrastructure, and increased patient awareness about minimally invasive treatments. The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, driven by improving healthcare facilities, a large patient pool, and rising awareness about viscosupplementation therapies.

Ask For Customization : https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/viscosupplementation-market-110550

Future Market Scope

The viscosupplementation market is poised for substantial growth in the coming years. Technological advancements leading to the development of more effective and longer-lasting hyaluronic acid formulations will enhance treatment outcomes. Increasing investments in healthcare infrastructure, especially in emerging economies, will improve access to viscosupplementation therapies. Additionally, ongoing research exploring the application of viscosupplementation in treating other joints beyond the knee, such as the hip and shoulder, will expand the market scope.

In conclusion, the viscosupplementation market is on an upward trajectory, driven by the rising prevalence of osteoarthritis, patient preference for minimally invasive treatments, and continuous advancements in hyaluronic acid-based therapies. Stakeholders in this market are focusing on innovation, strategic collaborations, and expanding their geographic reach to capitalize on the growing demand for effective osteoarthritis management solutions.

About Us:

Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.

Our reports are a blend of quantitative and qualitative analysis, aimed at helping businesses achieve sustainable growth. Our experienced analysts and consultants use leading research methodologies to provide comprehensive market assessments enriched with relevant data.

At Fortune Business Insights, we aim to highlight growth opportunities for our clients, offering insights and recommendations that help them navigate technological and market changes. Our consulting services are designed to help companies uncover hidden opportunities and address competitive challenges.

Contact us:

Fortune Business Insights™ Pvt.

Phone: USA: +1 833 909 2966 (Toll-Free),

United Kingdom: +44 808 502 0280 (Toll-Free),

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com